Fencamine

CAS : 28947-50-4

Ref. 3D-FF23246

Informations sur le produit

• Nom: Fencamine
• Synonymes: 3,7-Dihydro-1,3,7-trimethyl-8-[[2-[methyl(1-methyl-2-phenylethyl)amino]e thyl]amino]-1H-purine-2,6-dione8-[[2-[Methyl(α-methylphenet hyl)amino]ethyl]amino]caffeineAltimina, 1H-purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-8-[[2-[methyl(1-methyl-2-phenylethyl)amino]ethyl]amino]-, 3,7-Dihydro-1,3,7-trimethyl-8-[[2-[methyl(1-methyl-2-phenylethyl)amino]ethyl]amino]-1H-purine-2,6-dione, 8-[2-(N,α-Dimethyl-β-phenyl)ethylamino]-1,3,7-trimethyl-2,6-dioxopurine, 8-[[2-[Methyl(α-methylphenethyl)amino]ethyl]amino]caffeine, Altimina, Altimine, Caffeine, 8-[[2-[methyl(α-methylphenethyl)amino]ethyl]amino]-, N-8-Caffeyl-N′-methyl-N′-(α-methylphenethyl)ethylenediamine, N¹-(1,3,7-Trimethyl-2,6-dioxopurin-8-yl)-N²-(1-methyl)phenethyl-N²-methylethylenediamine, Phencamine, Sicoclor, dl-Fencamine

Description

Fencamine is a substrate molecule that is used in the synthesis of peptide hormones. It can be detected in urine samples and has been shown to be a synthetic cannabinoid. Fencamine can be used for diagnostic purposes. Fencamine has been shown to have matrix effects on the bowel disease, hepatitis, and hepatitis C., as well as exerting control analysis of the metabolite molecule. Fencamine has also been shown to have an effect on inflammatory bowel disease, hepatitis C., and toll-like receptor 2.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 384.48 g/mol
• Formule: C₂₀H₂₈N₆O₂
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder